Healthcare
Tenon Medical, Inc.(TNON)
Live Price
Offline$0.617
-0.96% today
1Y Change
-23.61%
Window
Jun 20, 2025 โ May 29, 2026
- Market Cap
- $10.00M
- Revenue Growth
- +20.4%
- EPS Growth
- +84.9%
- Dividend Yield
- 0.0%
Coverage: 237 bars ยท Jun 20, 2025 โ May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tenon Medical, Inc. (TNON) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $0.62 and down 23.6% across the available one-year price window (Jun 20, 2025 โ May 29, 2026). Baseline metrics include revenue growth of +20.4%, EPS growth of +84.9%, a dividend yield of 0.0%. What stands out right now is revenue +20.4%, EPS +84.9%, free cash flow -9.5% with operating margin -323.6% and ROIC -166.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TNON price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+20.4% vs +7.6% peer median
Operating Margin
Below sector median
-323.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 12, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +20.4% and EPS at +84.9%, with operating margin around -323.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -12.9% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 12, 2026 | โ | -11.5% | -14.0% | โ |
2026 Mar 19, 2026 | +38.9% | -3.9% | -12.1% | -4.0% |
2025 Nov 13, 2025 | -11.1% | +0.0% | -12.7% | -2.5% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TNON
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TNON Max Drawdown
-60.13%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TNON and SPY.
Company Overview
Tenon Medical, Inc.
NASDAQ Capital Market
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.
- Leadership
- Steven Foster
- IPO Date
- Apr 27, 2022
- Employees
- 27
- Street Address
- 104 Cooper Court
- Mailing
- Los Gatos, CA, 95032
- Region
- Los Gatos, CA, US
- Reporting Currency
- USD
- Investor Line
- (408) 649-5760
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 1.5
- Price/Book
- 1.7
Growth
- Revenue
- +20.4%
- EPS
- +84.9%
- Free Cash Flow
- -9.5%
Profitability
- Gross Margin
- 59.1%
- Operating Margin
- -323.6%
- Net Margin
- -316.0%
- ROE
- -193.2%
- ROIC
- -166.8%
Balance Sheet
- Debt/Equity
- 0.03
- Current Ratio
- 2.11
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.